Abstract: An environmentally safe, simple and robust spectrophotometric method has been developed for determination of H 2 -receptor antagonists namely: cimetidine (CIM), famotidine (FAM), nizatidine (NIZ), and ranitidine hydrochloride (RAN). The method was depend on the reaction of the studied drugs with N-bromosuccinimide (NBS) , environmentally friendly reagent, and the excess NBS was measured by its reaction with phloroglucinol to give a yellow chromogenic product (λ max at 435 nm). The absorption intensity decrease (ΔA) was correlated with drug concentrations in the sample solutions. By using of the optimum conditions, linear calibration curves with good correlation coefficients (0.9958-0.9998) were found between the measured ΔA values and the corresponding drugs concentrations in the range of 12-80 μg mL -1 . Limits of detection were in the range 1.31-2.21 μg mL -1 . The proposed method was validated and successfully applied for the analysis of the above mentioned drugs in their bulk and pharmaceutical dosage forms with good recoveries (98.5 ± 0.98 to 102.5 ± 0.79%). No interferences were obtained from the common excipients. The proposed method was successfully applied for the analysis of H 2 RAs in their dosage forms and the results were comparable with that obtained by the official methods.
Introduction
Histamine H 2 -receptor antagonists (H 2 RAs) are competitively inhibits the action of histamine on H 2 -receptors of parietal cells and thus reduces the gastric acid secretion under daytime and nocturnal basal conditions.. Therefore, these drugs are useful in treatment of active duodenal ulcer, gastric ulcer and Zollinger-Ellison Syndrome. These techniques were associated with some drawbacks as lack of sensitivity (titrimetry), time-consuming (TLC), requires expensive instruments that are not available in all quality control laboratories (HPLC and capillary electrophoresis). Spectrophotometric techniques provided practical (less-time consuming, simple, and more convenient) and significant economic advantages over other methods; therefore, they are a frequent choice for pharmaceutical analysis. [10] [11] [12] [13] [14] [15] [16] Therefore, the present work was directed to the development of new simple, accurate, and economic spectrophotometric method that overcomes these drawbacks. Nbromosuccinimide (NBS) is an environmental-friendly reagent which used as effective oxidizing/brominating agents. The spectrophotometric determinations involving NBS were based on direct measurement of the chromogenic derivative of the drug, or indirectly by measuring the remaining NBS with color-producing reagents. [17] [18] [19] [20] [21] [22] Phloroglucinol is easily susceptible to bromination with NBS and gives a yellow chromogenic product. The bromination of phloroglucinol occurs very rapidly with NBS due to presence of substitution sites activated by hydroxy-groups. 23 The purpose of the present work is to describe, for the first time, the use of a NBS/ phloroglucinol combination for determination of H 2 RAs. The analytical procedure based on oxidation of H 2 RAs with excess NBS and subsequent measurement of unreacted NBS by its reaction with phloroglucinol to give a yellow colored product that was measured at 435 nm. The decrease in the absorption intensity (ΔA) at 435 nm was directly proportional to the amount of the drug in the sample solution. 
Results and discussions
The use of molecular bromine as oxidizing and brominating agent has several drawbacks as it is harmful and there are difficulties in handling and maintaining the stoichiometric ratio during the reaction. From the green chemistry point of view, the replacement of such harmful reagents with nontoxic, inexpensive, commercially available and non-polluting reagents is an important goal. Recently, NBS has gained much attention as oxidation and bromination agent in determination of a variety of organic compounds including those of pharmaceuticals. [17] [18] [19] [20] [21] [22] NBS can be considered a convenient source of molecular bromine, or it can also act as a source of hypobromous acid which is the actual oxidizing agent.
Method Development
The proposed method using NBS and phloroglucinol is based on oxidation of the investigated H 2 RAs with a known excess amount of NBS and determination of the residual NBS by the reaction with phloroglucinol.
The decrease in the absorption intensity (ΔA) at λ max 435 nm was corresponding to the drug content in its sample solution ( Figure 2 ). It was observed that the reaction efficiency rise by increasing the concentration of NBS. The optimum absorbance (≈0.9) was obtained at a concentration of 0.45% (w/v) (Figure 3) , and thus this concentration was used in all further experiments. Similar series of experiments were performed to establish the optimum concentration of phloroglucinol reagent. The results revealed that the optimum concentration was 0.2% (w/v) ( Figure  4 ). For the reaction between NBS and phloroglucinol, the reaction was found to be rapid yielding a constant absorbance with maximum stability in presence of hydrochloric acid. 15, 17 Therefore, the optimum concentration of phloroglucinol solution, obtained by dissolving the reagent in diluted hydrochloric acid (2.5%; v/v), was found to be 0.2% w/v. The reaction was completed within 10-20 min at room temperature (25 ± 5 °C); therefore measurements were carried out after 15 min in order to achieve high precision ( Figure 5 ). Distilled water was preferred as a solvent for economic reasons and safe-environment considerations (green solvent). In water, the absorption values, at λ max 435 nm were found to be stable for at least 30 min.
Molar ratio and the reaction mechanism
The molar ratio of the reaction between the investigated H 2 RAs and NBS in ratio 1:4 (1 mole of drug reacted with 4 mole of NBS) as reported previously. 14, 15 Similarly, the reaction study of NBS with phloroglucinol revealed that NBS/phloroglucinol ratio was 4:1 ( Figure 6 ). 
Method validation Linearity, limits of detection and quantitation
The calibration graphs were linear with good correlation coefficients (0.9958-0.9998) between ΔA at λ max 435 nm, and various concentration ranges of drugs as indicated in Table 1 . The molar absorptivity and together with the limits of detection and quantification were also summarized in Table 1 . The limits of detection (LOD) and limits of quantitation (LOQ)
were determined 24 using the formula: LOD or LOQ = kSDa/b, where k = 3.3 for LOD and 10 for LOQ, SDa is the standard deviation of the intercept, and b is the slope.
Accuracy and Precision
Evaluation of the accuracy of the proposed method was carried out by using the standard addition method. The obtained recovery values were in the range 98.8-101.1% (Table 2 ). This indicated high accuracy of the proposed method. Five separate solutions of the working standards at three concentration levels were analyzed to evaluate the precision (repeatability) of the proposed method. Relative standard deviations were not exceeded 2.5 % indicating good precision (Table 3) .
Interferences
Recoveries obtained from the interferences study of the proposed method showed that; there is no interference was found from the commonly used excipients (starch, sucrose, lactose, and magnesium stearate). Ascorbic acid (added as stabilizer in the formulation of the ampoule) was found to interfere with the assay procedure. This interference could be eliminated by adding 1 mL of 0.1% (w/v) aqueous solution of potassium bromate to the ampoule samples prior to their analysis. 18 
Robustness and ruggedness
Robustness was examined by changing one parameter of the method whereas the others were kept unchanged, and the recovery percentage was observed each time. It was found that small variations in these variables did not affect the method significantly (Table 4) . Results obtained from lab-tolab and day-to-day variations in order to evaluate the ruggedness of the proposed method were found to be reproducible and RSD values were less than 2.5%.
Application to dosage forms
The validation of proposed method gave satisfactory results in 
Interferences study
The general recommended procedure of the proposed method was used for determination of CIM samples prepared by mixing a known amount (300 mg) of CIM with common excipients: starch, sucrose, lactose, magnesium stearate, and ascorbic acid (added as stabilizer in the formulation of the ampoule). The recovery values were determined in order to determine the effects of these excipients.
Analysis of dosage forms Tablets and capsules
Twenty tablets or contents of 20 capsules were weighed accurately and ground into a fine powder. A quantity of powder equivalent to 200 mg of the active ingredient was accurately into a 100-mL volumetric flask and dissolved in about 50 mL of water. The content was shaken for about 20 min; the mixture was diluted to the mark with the water, mixed, and filtered.
Firstly, a 10 mL portion of the filtrate was discarded, and a convenient aliquot was taken. Secondly, the assay was completed according to an earlier described procedure.
Ampoules
The contents of five ampoules were quantitatively transferred into a 250-mL volumetric flask, the volume was diluted to the mark with water, mixed, and the resulting solution was used for analysis according with the recommended procedure.
Determination of molar ratio of the reaction of NBS and phloroglucinol
One-milliliter aliquots of NBS solution (6.6 x 10 
Conclusions
The results presented in this study demonstrate that it is possible to use a NBS/phloroglucinol coupled assay for spectrophotometric determination of H 2 -receptor antagonists. The proposed method was advantageous over the previously reported spectrophotometric methods in terms of simplicity, cost-effectiveness and applicability to analysis of four H 2 RAs. 
